Related Experiment Video
Updated: Jul 19, 2026

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities
Simone Mocellin1, Vincenzo Bronte, Donato Nitti
1Department of Oncological and Surgical Sciences, School of Medicine, University of Padova, Padova, Italy. mocellins@hotmail.com
Abstract:
Nitric oxide (NO) is a pleiotropic molecule critical to a number of physiological and pathological processes. The last decade has witnessed major advances in dissecting NO biology and its role in cancer pathogenesis. However, the complexity of the interactions between different levels of NO and several aspects of tumor development/progression has led to apparently conflicting findings. Furthermore, both anti-NO and NO-based anticancer strategies appear effective in several preclinical models. This paradoxical dichotomy is leaving investigators with a double challenge: to determine the net impact of NO on cancer behavior and to define the therapeutic role of NO-centered anticancer strategies. Only a comprehensive and dynamic view of the cascade of molecular and cellular events underlying tumor biology and affected by NO will allow investigators to exploit the potential antitumor properties of drugs interfering with NO metabolism. Available data suggest that NO should be considered neither a universal target nor a magic bullet, but rather a signal transducer to be modulated according to the molecular makeup of each individual cancer and the interplay with conventional antineoplastic agents.
Insights
Nitric oxide (NO) impacts cancer through complex mechanisms, yielding conflicting results. NO is a signal transducer, not a universal target, requiring tailored cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Nitric oxide (NO) is a key molecule in physiological and pathological processes.
- Recent advances highlight NO's complex role in cancer development and progression.
- Conflicting findings exist regarding NO's net impact on tumor behavior.
Purpose of the Study:
- To clarify the dual role of nitric oxide in cancer pathogenesis.
- To define the therapeutic potential of nitric oxide-centered anticancer strategies.
- To understand the complex interactions between NO levels and tumor development.
Main Methods:
- Review of existing literature on nitric oxide biology in cancer.
- Analysis of preclinical data on anti-NO and NO-based anticancer strategies.
- Integration of molecular and cellular events affected by NO in tumor biology.
Main Results:
- Nitric oxide exhibits both pro- and anti-tumorigenic effects.
- Both NO-lowering and NO-releasing strategies show efficacy in preclinical cancer models.
- The precise impact of NO depends on context and concentration.
Conclusions:
- Nitric oxide is a complex signal transducer in cancer, not a simple target.
- Therapeutic strategies targeting NO must be individualized based on cancer's molecular profile.
- Modulating NO metabolism requires a dynamic understanding of tumor biology and drug interactions.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis

